Control of microbial contamination in unpreserved eyedrops

British Journal of Ophthalmology

Volumn 80, Issue 7, 1996, Pages 588-591

  Oldham, Gillian B ^a   Andrews, Victor ^a  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID; ANTIBIOTIC AGENT; ARTIFICIAL TEAR; EYE DROPS; PRESERVATIVE; STEROID;

ARTICLE; BACTERIUM CONTAMINATION; DRUG STORAGE; FREEZING; PRIORITY JOURNAL;

EID: 0029756198     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.80.7.588     Document Type: Article

References (32)

1. British Pharmacopoeia. London: HMSO, 1993:736.
2. Barkman R, Germanis M, Karpe G, Malmborg S. Preservatives in eyedrops. Acta Ophthalmol 1969;47:461-75.
3. Wilson WS, Duncan AJ, Jay JL. Effect of benzalkonium chloride on the stability of the precorneal tear film in rabbit and man. Br J Ophthalmol 1975;59:667-9.
4. Tripathi BJ, Tripathi RC. Cytotoxic effects of benzalkonium chloride and chlorbutanol on human corneal epithelial cells in vitro. Lens Eye Toxic Res 1989;6:395-403.
5. Hertel F, Pfeiffer N. Einzeldosisapplikationen in der Glaukomtherapie. Vergleich der Kosten mit Mehrdosis. Ophthalmologe 1994;91:602-5.
6. British National Formulary. No 28. Control of microbial contamination. London: The Pharmaceutical Press, Sept 1994:399.
7. British Pharmaceutical Codex. London: The Pharmaceutical Press, 1973:685-7.
8. Health Service Circular. Preservation of sterility in ophthalmic preparations in hospitals. London: DHSS, HSC(IS)122, March 1975.
9. United States Pharmacopeia, XXIII. Rockville, MD: United States Pharmacopeial Convention Inc, 1995:1681.
10. Medicines Act Information Leaflet No 45. London: Medicines Control Agency, Department of Health, November 1985.
11. Davison AL, Hooper WL, Spooner DF, Farwell JA, Baird R. The validity of the criteria of pharmacopoeial preservative efficacy tests - a pilot study. Pharm J 1991;246:555-7.
12. Guest HE, Hanlon GW, Livingstone DJ. Microbial evaluation of preservative-free eyedrops in multiple application containers. Pharm J 1990;24S(Suppl 29):R17.
13. Livingstone DV, Guest HE. Keep patients' eyes free of infection. Hospital Pharmacy Practice 1994;4:301-3.
14. Ford JL, Brown MW, Hunt PB. A note on the contamination of eyedrops following use by hospital out-patients. J Clin Hosp Pharm 1985;10:203-9.
15. Moorfields Eye Hospital Formulary. London: Pharmacy Department, Moorfields Eye Hospital, 1992.
16. European Pharmacopoeia. 2nd ed. VIII 14. Efficacy of antimicrobial preservation. France: Maisonneuve SA, 1994.
17. Anon. Pharmeuropa 1993;5:355-358.
18. Kruyswijk MR, Polak BC. Contactallergie na toepassing van oogdruppels en oogzalven. Ned Tijdschr Geneeskd 1980;124: 1449-52.
19. Lemp MA, Zimmerman LE. Toxic endothelial degeneration in ocular surface disease treated with topical medications containing benzalkonium chloride. Am J Ophthalmol 1988; 105:670-3.
20. Van Horn DL, Edelhauser HF, Prodanovich G, Eiferman R, Pederson HF. Effect of the ophthalmic preservative thiomerosal on rabbit and human corneal endothelium. Invest Ophthalmol Vis Sci 1977;16:273-80.
21. Collin HB. Ultrastructural changes to corneal stromal cells due to ophthalmic preservatives. Acta Ophthalmol 1986;64: 72-8.
22. Collin HB, Grabsch BE. The effect of ophthalmic preservatives on the healing rate of the rabbit corneal epithelium after keratectomy. Am J Optom Physiol Opt 1982;59:215-22.
23. Burstein NL. Corneal cytotoxicity of topically applied drugs, vehicles and preservatives. Surv Ophthalmol 1980; 25:15-30.
24. Laflamme MY, Swieca R. A comparative study of two preservative-free tear substitutes in the management of severe dry eye. Can J Ophthalmol 1988;23:174-6.
25. Seal D, Ficker L, Wright P, Andrews V. The case against thiomersal. Lancet 1991;338:315-6.
26. Gobbels M, Spitznas M. Influence of artificial tears on corneal epithelium in dry-eye syndrome. Graefes Arch Clin Exp Ophthalmol 1989;227:139-41.
27. Mietz H, Niesen U, Krieglstein GK. The effect of preservatives and antiglaucomatous medication on the histopathology of the conjunctiva. Graefes Arch Clin Exp Ophthalmol 1994;232:561-5.
28. Caffery BE, Josephson JE. Is there a better 'comfort drop'? J Am Optom Assoc 1990;61:178-82.
29. Marquardt R, Schubert T. Beeinflussung der Tranenfilmaufreisszeit (BUT) durch Betablocker-Augentropfen ohne Konservierungsstoffe. Klin Monatsbl Augenheilkd 1991;199: 75-8.
30. Conrads H, Winterhoff D, Strotmann U. Wert und Unwert von Konservierungsmitteln in Augentropfen. Praxisumfragen und experimentelle Untersuchungen zur Forderung des DAB 8/78. Klin Monatsbl Augenheilkd 1984;184:233-7.
31. Longfield RN, Smith LP, Longfield JN, Coberly J, Cruess D. Multiple-dose vials: persistence of bacterial contaminants and infection control implications. Infection Control 1985;6:194-9.
32. Pinney RJ. Survival of plasmid-containing strains of E coli, P aeruginosa and S aureus in phenylmercuric nitrate and thiomersal. J Pharm Pharmacol 1978;30:228-32.